Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2021 11:32 ET | Source: Tricida, Inc.

Tricida to Report First Quarter Financial Results and Host Conference Call and Webcast on Thursday, May 6, 2021

SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2021 financial results after the close of market on...
April 08, 2021 12:15 ET | Source: Tricida, Inc.

Tricida to Present at the Needham Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday,...
April 05, 2021 08:30 ET | Source: Tricida, Inc.

Tricida Announces Multiple Data Presentations to Be Given at the Virtual National Kidney Foundation 2021 Spring Clinical Meetings

SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
March 03, 2021 08:30 ET | Source: Tricida, Inc.

Tricida Granted Additional U.S. Patent Covering Composition of Matter of Veverimer

SOUTH SAN FRANCISCO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
February 25, 2021 16:10 ET | Source: Tricida, Inc.

Tricida Announces Fourth Quarter and Full Year 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
February 25, 2021 16:05 ET | Source: Tricida, Inc.

Tricida Provides Update on FDA Interactions

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
February 22, 2021 11:50 ET | Source: Tricida, Inc.

Tricida to Report Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on Thursday, February 25, 2021

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its fourth quarter and year-end 2020 financial results after the close...
January 06, 2021 16:30 ET | Source: Tricida, Inc.

Tricida to Present at the 39th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday,...
December 08, 2020 16:05 ET | Source: Tricida, Inc.

Tricida Announces Updates on Veverimer Development Program, Regulatory Status and New Patent Extending Protection through 2038

SOUTH SAN FRANCISCO, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
December 07, 2020 16:05 ET | Source: Tricida, Inc.

Tricida to Provide an End-of-Year Business Update

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...